Evaluation of Pharmacokinetics, Safety, and Tolerability of Ceftazidime-avibactam in Neonates and Infants.

Clinical trial NCT04126031 · TERMINATED

Trial details

NCT number: NCT04126031
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Gram-negative Bacterial Infection

Start date: 2020-01-14
Primary completion: 2022-12-30
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.